For patients with suspected interstitial lung disease, the digital biomarker solution Fibresolve offers machine learning capability of diagnosing idiopathic pulmonary fibrosis (IPF) based on assessment of lung computed tomography (CT) scans.

Utilized for neurological procedures including biopsies, catheter placement and electrode introduction, the SmartFrame OR Stereotactic System can be combined with preoperative MRI or CT to ensure optimal placement of devices and instruments.

The use of actinium-225 PSMA radioligand therapy led to PSA level decreases of at least 50 percent in 57 percent of patients and a median progression-free survival rate of 7.9 months in patients with metastatic castration-resistant prostate cancer (mCRPC), according to newly published research.

Review the case and test your knowledge to make the correct diagnosis.

Featuring a lightweight body contouring design, the Small Body Array reportedly facilitates optimal signal-to-noise ratio (SNR) and between 10 and 40 percent faster throughput.

In addition to detecting more than double the number of distant lymph nodes and distant lesions in comparison to conventional imaging with computed tomography (CT), PSMA PET/CT reportedly changed management for 32 percent of patients.

While CT, MRI and X-rays provide more of a workout for one’s radiological skills, more occasional spurts of DEXA scans and Doppler ultrasounds can provide comfortable diversions on worklists.

Catch up on the top radiology content of the past week.

The FDA has accepted Lantheus' abbreviated new drug application for a generic Lutathera, just months after Novartis announced positive phase 3 data supporting a first-line indication for the radiopharmaceutical in neuroendocrine tumors.

Patients with benign pulmonary absorbable subsolid nodules (AB-SSNs) have a greater frequency of nodules in comparison to those with non-absorbable benign subsolid nodules (NB-SSNs) and patients with malignant subsolid nodules (M-SSNs), according to a recent study of follow-up non-contrast CT exams in over 400 patients.

Utilizing brain MRI and cognitive assessments, the newly FDA-approved, AI-powered software platform BrainSee can reportedly predict the progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s dementia within five years.

Noting the challenges with angiography in the imaging of lower extremity revascularization, a panel of interventional radiologists, interventional cardiologists and vascular surgeons discussed emerging evidence that supports the use of intravascular ultrasound in facilitating improved outcomes in this high-risk patient population.

In addition to high-quality X-ray and fluoroscopic images, the DRX-Excel Plus X-ray System provides automated filter selection, grid parking and positioning of table axes.

In part of an ongoing multicenter study evaluating commercial artificial intelligence (AI) products in radiology, AI lung nodule detection software from four out of seven vendors demonstrated stand-alone AUCs ranging from 5 to 12 percent higher than the mean AUC of 17 reviewing radiologists.

Offering enhanced utility for assessing urinary incontinence, bladder emptying and urinary retention, the Clarius Bladder AI ultrasound software reportedly provides bladder volume measurement in seconds.

A comfortable environment for reading CTs, MRIs and X-rays may be conducive to less interruptions and longer intervals at radiology workstations.

Tailored for incidental findings on chest radiographs, the qXR for Lung Nodule (qXR-LN) software utilizes artificial intelligence (AI) to help detect suspected pulmonary nodules ranging between 6 to 30 mm.

A model that combines multiparametric MRI findings with clinical factors may enhance the accuracy of predicting clinically significant prostate cancer and significantly reduce unnecessary systematic prostate biopsies in biopsy-naïve patients.

Modifications to the radiology workflow, including the use of a structured report template, improved adherence for 30-minute turnaround times for acute stroke head CT results from 73.2 percent to 95.6 percent, accordingly to new research.

The BioTraceIO software reportedly facilitates visualization of liver tumor ablation procedures based on real-time ultrasound imaging and provides superior post-op estimates of ablation zone volume in comparison to computed tomography.